Pediatric Infection and Vaccine

The Korean Society of Pediatric Infectious Diseases (대한소아감염학회)
권호 표지
DOI QR코드

DOI QR Code

Severe SARS-CoV-2 Infection With Multiorgan Involvement Followed by MIS-C in an Adolescent

  • Bomi Lim (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Su-Mi Shin (Department of Radiology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center) ;
  • Mi Seon Han (Department of Pediatrics, Seoul Metropolitan Government-Seoul National University Boramae Medical Center)
  • Received : 2022.07.25
  • Accepted : 2022.12.15
  • Published : 2022.12.25
Download PDF
⟨ Previous Next ⟩

Abstract

Children and adolescents with coronavirus disease 2019 (COVID-19) generally have mild symptoms. Severe infection due to severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) involving multiorgan dysfunction is rare in this population. Herein, we present an unusual case of severe SARS-CoV-2 infection with multiorgan involvement followed by multisystem inflammatory syndrome in children (MIS-C) in a vaccinated 16-year-old boy. The patient was unconscious on initial presentation, and had severe paralytic ileus. On laboratory examination, there was severe metabolic acidosis, lymphocytopenia, thrombocytopenia, elevated inflammatory markers, elevated liver enzymes, and evidence of acute kidney injury with proteinuria and hematuria. His symptoms improved with the administration of remdesivir and dexamethasone. The patient briefly experienced MIS-C 2 weeks after the diagnosis of COVID-19, but the patient was discharged without any complications.

코로나19로 확진된 소아와 청소년은 대개 경한 증상을 나타내며 SARS-CoV-2 감염으로 인한 다기관 기능부전은 매우 드물다. 저자들은 코로나19 예방접종을 완료한 16세 청소년에게서 발생한 다기관을 침범한 심한 SARS-CoV-2 감염에 대해 보고하고자 한다. 환자는 내원 당시 의식이 없었으며 심한 마비성장폐색증이 있었다. 혈액검사 상 심한 대사성 산증과 함께 림프구감소증, 혈소판감소증, 염증 수치 상승, 간수치 상승, 단백뇨와 혈뇨가 동반된 급성 신손상의 증거가 있었다. 환자의 상태는 렘데시비르와 덱사메타손 투여와 함께 점차 호전되었다. 코로나19 확진 2주 후에 환자는 다기관염증증후군을 짧게 경험하였으나 특별한 합병증 없이 퇴원하였다.

Keywords

References

  1. Cui X, Zhao Z, Zhang T, Guo W, Guo W, Zheng J, et al. A systematic review and meta-analysis of children with coronavirus disease 2019 (COVID-19). J Med Virol 2021;93:1057-69.  https://doi.org/10.1002/jmv.26398
  2. Irfan O, Muttalib F, Tang K, Jiang L, Lassi ZS, Bhutta Z. Clinical characteristics, treatment and outcomes of paediatric COVID-19: a systematic review and meta-analysis. Arch Dis Child 2021;106:440-8.  https://doi.org/10.1136/archdischild-2020-321385
  3. Kompaniyets L, Agathis NT, Nelson JM, Preston LE, Ko JY, Belay B, et al. Underlying medical conditions associated with severe COVID-19 illness among children. JAMA Netw Open 2021;4:e2111182. 
  4. Fernandes DM, Oliveira CR, Guerguis S, Eisenberg R, Choi J, Kim M, et al. Severe acute respiratory syndrome coronavirus 2 clinical syndromes and predictors of disease severity in hospitalized children and youth. J Pediatr 2021;230:23-31.e10.  https://doi.org/10.1016/j.jpeds.2020.11.016
  5. Shekerdemian LS, Mahmood NR, Wolfe KK, Riggs BJ, Ross CE, McKiernan CA, et al. Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr 2020;174:868-73.  https://doi.org/10.1001/jamapediatrics.2020.1948
  6. Centers for Disease Control and Prevention. CDCHAN-00432, May 14, 2020. Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19) [Internet]. Atlanta: Centers for Disease Control and Prevention; 2020 [cited 2022 May 24]. Available from: https://emergency.cdc.gov/han/2020/han00432.asp. 
  7. Lindan CE, Mankad K, Ram D, Kociolek LK, Silvera VM, Boddaert N, et al. Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study. Lancet Child Adolesc Health 2021;5:167-77. 
  8. Beaudry JT, Dietrick B, Lammert DB, Constas A, McCaw J, Hammond J, et al. Fatal SARS-CoV-2 inflammatory syndrome and myocarditis in an adolescent: a case report. Pediatr Infect Dis J 2021;40:e72-6.  https://doi.org/10.1097/INF.0000000000002978
  9. Bjornstad EC, Seifert ME, Sanderson K, Feig DI. Kidney implications of SARS-CoV2 infection in children. Pediatr Nephrol 2022;37:1453-67.  https://doi.org/10.1007/s00467-021-05249-8
  10. Dallan C, Romano F, Siebert J, Politi S, Lacroix L, Sahyoun C. Septic shock presentation in adolescents with COVID-19. Lancet Child Adolesc Health 2020;4:e21-3.  https://doi.org/10.1016/S2352-4642(20)30164-4
  11. Joshi K, Kaplan D, Bakar A, Jennings JF, Hayes DA, Mahajan S, et al. Cardiac dysfunction and shock in pediatric patients with COVID-19. JACC Case Rep 2020;2:1267-70.  https://doi.org/10.1016/j.jaccas.2020.05.082
  12. Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32.  https://doi.org/10.1038/s41591-020-0968-3
  13. Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020;181:271-280.e8.  https://doi.org/10.1016/j.cell.2020.02.052
  14. Chou J, Thomas PG, Randolph AG. Immunology of SARS-CoV-2 infection in children. Nat Immunol 2022;23:177-85. 
  15. Nemani K, Li C, Olfson M, Blessing EM, Razavian N, Chen J, et al. Association of psychiatric disorders with mortality among patients with COVID-19. JAMA Psychiatry 2021;78:380-6.  https://doi.org/10.1001/jamapsychiatry.2020.4442
  16. Mokhtari R, Lachman HM. The major histocompatibility complex (MHC) in schizophrenia: a review. J Clin Cell Immunol 2016;7:479. 
  17. Steiner J, Jacobs R, Panteli B, Brauner M, Schiltz K, Bahn S, et al. Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity. Eur Arch Psychiatry Clin Neurosci 2010;260:509-18.  https://doi.org/10.1007/s00406-010-0098-x
  18. De Leon J, Sanz EJ, De Las Cuevas C. Data from the World Health Organization's pharmacovigilance database supports the prominent role of pneumonia in mortality associated with clozapine adverse drug reactions. Schizophr Bull 2020;46:1-3.  https://doi.org/10.1093/schbul/sbz093
  19. Centers for Disease Control and Prevention. Information for healthcare providers about multisystem inflammatory syndrome in children (MIS-C) [Internet]. Atlanta: Centers for Disease Control and Prevention; 2021 [cited 2022 May 24]. Available from: https://www.cdc.gov/mis-c/hcp/. 
  20. Kaushik A, Gupta S, Sood M, Sharma S, Verma S. A systematic review of multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection. Pediatr Infect Dis J 2020;39:e340-6.   https://doi.org/10.1097/INF.0000000000002888